Advisory Services Network’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Advisory Services Network’s Portfolio FTXH Stock Details FTXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.92M	Buy	+142,634	New	+$5.74M	0.07%	272

Other funds holding FTXH

First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

Nilsine Partners Greenwood Village, Colorado $1.44B AUM 38.08% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $34.5B AUM 23.55% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

NewSquare Capital Newtown Square, Pennsylvania $1.38B AUM 24% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $9.42B AUM 19.31% 1-Year Est. Return

Benjamin Edwards Inc Clayton, Missouri $11.1B AUM 12.46% 1-Year Est. Return

Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Advisory Services Network's FTXH Position: Q3 2026 in Review

Advisory Services Network opened a new position in First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q3 2026: 142,634 shares worth $5.92M. The stake represents 0.07% of the portfolio and ranks #272 among its holdings.

57 funds tracked by Wall St. Rank hold FTXH as of Q3 2026.

Advisory Services Network held 142,634 shares of First Trust Nasdaq Pharmaceuticals ETF worth $5.92M as of Q3 2026.
First Trust Nasdaq Pharmaceuticals ETF was a new Advisory Services Network position in Q3 2026.
First Trust Nasdaq Pharmaceuticals ETF made up 0.07% of Advisory Services Network's portfolio in Q3 2026, its #272 holding.
57 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q3 2026.

Based on Advisory Services Network's 13F filing for Q3 2026, filed 13 Nov 2026.